A series of halogen containing 1,4-naphthoquinon derivatives (1-4,5a-f) were synthesized and studied for their antifungal activities against C. albicans ATCC10231, C. albicans 955, T. mentagrophytes and M. gypseum. The results indicate that compound 2-hydroxy-3-chloro-1,4-naphthoquinone (2), 2-(N-acetyl)-acetamido-3-chloro-1,4-napthoquinone (3) and 2-(N-acetyl)-acetamido-3-chloro-1,4-napthoquinone (4) have potent antifungal activity. Among these promising antifungal candidates, 2 and 4 showed better activity than that of clinically antifungal drug clotrimazole (MIC = 8 μg/ml) with MIC = 1 μg/ml and 4 μg/ml, respectively against C.albicans ATCC10231. Compound 2 also exhibited an extremely potent activity (MIC = 0.25 μg/ml) against C.albicans 955 strain compared with clotrimazole (MIC = 16 μg/ml). Structure and activity relationship (SAR) study demonstrated that replacing of 3-position in 1,4-naphthoquinon by a Cl group is essential for antifungal activity. Meanwhile, antifungal activity was decreased considerably when the hydrogen atom at position-2 in naphthoquinone structure were replaced by a bulky group (e.g. diacetyl of phenyl group).
BACKGROUND
The increase in the incidence of fungal infections may be attributed primarily to increased numbers of critically ill and immunocompromised patients, including those with AIDS, cancer patients undergoing chemotherapy, and organ transplant recipients taking immunosuppressive drugs. 1 However azole derivatives including fluconazole and itraconazole are widely used in clinical settings but there are major weaknesses in their spectra, potency, safety and pharmacokinetic properties. In addition, the emergence of fungal strains resistant to existing antifungal drugs is becoming a significant problem. Thus the development of new effective antifungal agents is strongly needed in medicine. [2] [3] Quinones, in particular benzoquinone and naphthoquinone derivatives, have been repeatedly isolated from lower as well as higher species of plants, and are found frequently in animals. 4 In addition to quinones possessing a biological function in cell metabolism as electron carriers, other compounds of this class have been found active against bacteria and fungi. [5] [6] [7] [8] [9] [10] Recently, many studies have demonstrated that naphthoquinone derivatives substituted with a halogen atom show a particularly marked activity against fungi. [11] [12] [13] [14] The present study was carried out to design and synthesis a series of halogen containing 1,4-naphthoquinone derivatives and test against several fungal pathogens.
MATERIALS AND METHODS

Chemistry
The reagents and the solvents used in this study were of analytical grade were used without further purification. Lawsone was synthesized according to the previous publication. 15 2-amino-3-chloro-1,4-naphthoquinone and 2,3-dichloro-1,4-naphthoquinone were purchased
form Acros. Progress of reactions and purity of compounds were monitored by thin layer chromatography (TLC), which was performed on silica gel 60F254 and compounds were detected with UV Chamber at 254nm and 365nm (where required). Column chromatography was performed on silica gel G60 (230-400 mesh, ASTM, Merck). All melting points were measured in open capillary tubes using Galenkampt melting point and were uncorrected. UV-Vis spectra were taken with a Hitachi U-2010 spectrophotometer. IR spectra were recorded on Schimadzu FTIR 8201 PC Spectrophotometers. Proton Nuclear Magnetic Resonance ( 1 H NMR) spectra were recorded on Bruker Ultrashield 500 spectrometers using tetramethylsilan (TMS) as an internal reference. Chemical shifts were given in ppm with TMS as a standard. ESI mass spectra (ESI-MS) were obtained on Waters Quattro micro API mass spectrometer.
In order to study the structure-activivity relationship (SAR) of halogen substituted 1,4-naphthoquinone derivatives, several 1,4-naphthoquinon were synthesized (see Scheme 1). Scheme 1. Synthesis of novel halogen substituted 1,4-naphthoquinones 2-Methoxy-3-bromo-1,4-naphthoquinone (1) was obtained by two-step-reaction. Fistly, bromination of lawsone with bromine and hydroperoxide in acidic medium provide 2-hydroxy-3-bromo-1,4-naphthoquinone in good yield (92%). This compound was then reacted with dimethylsulfate in acetone to obtain 1 as a yellow solid. The methylation reaction was catalysted by K 2 CO 3 .
Form 2-amino-3-chloro-1,4-naphthoquinone, we have successfully carried out the synthesis of several chloro-1,4-naphthoquinone analogs (2-4). 2-hydroxy-3-chloro-1,4-naphthoquinone (2) was obtained by the diazoniation of 2-amino-3-chloro-1,4-naphthoquinone with sodium nitrite as reagent, the mixture was then hydrolyzed at 50 o C providing 2 as an orange solid. On the other hand, reaction of 2-amino-3-chloro-1,4-naphthoquinone with several acid anhydride producing two amino substituted derivatives (3-4) in average yields, concentrated H 2 SO 4 was used as catalyst. 13 The reaction of 2,3-dichloro-1,4-naphthoquinone with arylamine was carried out in absolute methanol at 50-60 o C. Only one chlorine atom of 2,3-dichloro-1,4-naphthoquinone was substituted by the nucleophile arylamines due to electronic enrichment of the quinone structure. 10, 14 We have studied this reaction with six different aryl amine (shown in Scheme 1) to obtain six different arylamine analogs of naphthoquinone (5a-f).
In vitro antifungal activities
The compounds 1-4 and 5a-f were evaluated for their in vitro antifungal activity against C. albicans ATCC10231, C. albicans 955, T. mentagrophytes and M. gypseum by diffusion technique and minimum inhibitory concentration (MIC) assay. 16 
Diffusion technique
All fungi were grown in Sabouraud Dextrose Agar (SDA) medium. Lorian disks were soaked with 2.5μL solution 10mg/mL of substances (1-4, 5a-f) in DMSO. Disks were put on an exponentially growing plated culture with appropriate dilution to 10 -6 colony forming unit (CFU mL -1 ). The plates were then incubated for 2 days (C. albicans) and 7 days (dermatophytes) at 37 o C. The results were recorded by measuring the zones surrounding the disk. Control disk containing DMSO and clotrimazole was used as reference in the assay.
MIC assay
In this process MIC of compounds 1-4 and 5a-f were tested according to standard microbroth dilution. Briefly, testing was performed in flat-bottomed 96-well tissue culture plate in SDA medium. The tested compounds was dissolved in DMSO and the concentration range was 64 -0.5 μg/mL. Initial inocula of fungal strains were maintained at 10 -3 CFU.mL -1 (C. albicans) and 10 -4 CFU.mL -1 (dermatophytes). These plates were incubated in a moist chamber at 37 o C for 2 days (C. albicans) or 7 days (dermatophytes), before being read. MIC was defined as the lowest compound concentration preventing visible fungal growth. Clotrimazole was used as antifungal standard substance.
RESULTS AND DISCUSSION
Chemistry
Procedure for the synthesis of 2-methoxy-3-bromo-1,4-naphthoquinone (1)
Synthesis of 2-hydroxy-3-bromo-1,4-naphthoquinone from lawsone
A stirred solution of lawsone (1g, 5.7 mmol) in chloroform (100mL) was cooled to 20 o C and then 11.5ml H 2 SO 4 2N was added. The mixture was then slowly added bromine (1.17ml; 3 mmol), and 0.7ml of solution H 2 O 2 30%. The reaction was monitored by TCL until complete consumption of lawsone. The reaction was allowed to warm to room temperature and then a solution of Na 2 S 2 O 3 10% was added to eliminate any bromine remaining. The reaction mixture was extracted with chloroform. The combined organic phase was dried over anhydrous Na 2 SO 4 
Synthesis of 2-methoxy-3-bromo-1,4-naphthoquinone (1)
To a solution of 2-hydroxy-3-bromo-1,4-naphthoquinone (0.3g, 1.2 mmol) in acetone was slowly added solid K 2 CO 3 (0.1794g, 1.3 mmol) and dimethylsulfat (0.124ml, 1.3 mmol) . The mixture was refluxed in 6 hours and then was filtered to eliminate the solid K 2 CO 3 
Synthesis of 2-(N-acetyl)-acetamido-3-chloro-1,4-napthoquinone (3)
To a suspension of 2-amino-3-chloro-1,4-naphthoquinone (6. 
Synthesis of 2-ethylcarboxamido-3-chloro-1,4-naphthoquinone (4)
Antifungal activity
These 1,4-naphthoquinone derivatives (1-4, 5a-f) subjected to the in vitro antifungal test.
Results ( The MIC of compounds 1-4 and 5a-f were compared with that of clotrimazole (shown in Table 2 ). The results showed that compound 2 (MIC = 1 μg/ml), 4 (MIC = 4 μg/ml) had better activity than and compound 3 (MIC = 8 μg/ml) had same antifungal profile with clotrimazole against C. albicans ATCC10231. Compounds 2 and 4 (MIC = 0.25 and 32 μg/ml, respectively) also exhibited a promising antifungal activity on comparison with antifungal drug such as clotrimazole. The results revealed that substituted 1,4-naphthoquinone posses potent antifungal activity against C. albicans when 3-position is replaced by Cl group (2 and 4) . The MIC values of tested compounds also demonstrated that antifungal activity was decreased considerably when the hydrogen atom at position-2 in naphthoquinone structure were replaced by a bulky group such as diacetyl (3) of phenyl group (5a-f).
CONCLUSION
In conclusion, we have synthesized a series of novel halogen substituted 1,4-naphthoquinone. The antifungal profile of these compounds indicated that compounds 2, 3 and 4 have potent antifungal activity. Among these promising antifungal candidates, 2-hydroxy-3-chloro-1,4-naphthoquinone (2) and 2-ethylcarboxamido-3-chloro-1,4-naphthoquinone (4) showed better antifungal activity than that of the clinically prevalent antifungal drug clotrimazole against C. albicans ATCC10231 and the drug-resistant C. albicans 955.
